The Neuralert Stroke Monitor Pilot Trial
Condition(s) studied
Investigational drug(s) / intervention(s)
Neuralert Monitor: Device to identify upper extremity asymmetry in patients who are high risk for stroke.
Study summary
This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of wearing a Neuralert device on each arm. For this pilot trial, we are interested in learning about Wi-Fi connectivity, successful data transmission, integration into clinical workflow, usability and tolerability.
Eligibility
Primary outcome measure(s)
- Time to Nursing Response — Up to 5 days post patient surgery
The time from the nurse receiving an alert to the time they respond after assessing the patient. - Time to Generate Alert — Up to 5 days post patient surgery
The time to successful generation of an alert to staff when asymmetry or low battery is detected.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | Recruiting |
More Neuralert Technologies LLC trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06368193 on ClinicalTrials.gov ↗ ← All trials in the USA